Standard BioTools Inc. (LAB) stock
LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3085% below fair value
$0.71+0.06 (+8.60%)
Close on Nov 13, 2026Market cap $277.71MP/E 3.2Yield –
Standard BioTools market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Standard BioTools's market cap was $252.13M on Nov 11, 2026, against $575.42M a year earlier. Over the last 5 years it ranged from $86.52M to $943.39M, with a median of $283.06M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $252.13M | -48.7% |
| 2025 | Dec 31, 2025 | $491.03M | -24.6% |
| 2024 | Dec 31, 2024 | $651.46M | +270.9% |
| 2023 | Dec 29, 2023 | $175.63M | +89.4% |
| 2022 | Dec 30, 2022 | $92.72M | -69.1% |
| 2021 | Dec 31, 2021 | $299.82M | -32.6% |
| 2020 | Dec 31, 2020 | $444.69M | +83.7% |
| 2019 | Dec 31, 2019 | $242.03M | -28.6% |
| 2018 | Dec 31, 2018 | $338.90M | +49.0% |
| 2017 | Dec 29, 2017 | $227.48M | +7.3% |
| 2016 | Dec 30, 2016 | $211.98M | -31.9% |
| 2015 | Dec 31, 2015 | $311.18M | -67.3% |
| 2014 | Dec 31, 2014 | $952.40M | -2.8% |
| 2013 | Dec 31, 2013 | $979.62M | +174.0% |
| 2012 | Dec 31, 2012 | $357.58M | +34.3% |
| 2011 | Dec 30, 2011 | $266.25M | – |
See a number that looks wrong?